Inhibrx Biosciences | 4: Statement of changes in beneficial ownership of securities-Director Vuori Kristiina MD
Inhibrx Biosciences | 4: Statement of changes in beneficial ownership of securities-Officer Lappe Mark
Inhibrx Biosciences | 4: Statement of changes in beneficial ownership of securities-Director Vuori Kristiina MD
Inhibrx Biosciences | 4: Statement of changes in beneficial ownership of securities-Officer Lappe Mark
Inhibrx Biosciences | 4: Statement of changes in beneficial ownership of securities-Officer Lappe Mark
Inhibrx Biosciences | 4: Statement of changes in beneficial ownership of securities-Director Vuori Kristiina MD
Inhibrx Biosciences | 4: Statement of changes in beneficial ownership of securities-Director MANHARD KIMBERLY
Inhibrx Biosciences | 4: Statement of changes in beneficial ownership of securities-Director FORSYTH DOUGLAS
Inhibrx Biosciences | 4: Statement of changes in beneficial ownership of securities-Officer Lappe Mark
4: Statement of changes in beneficial ownership of securities-Director Kayyem Jon Faiz
4: Statement of changes in beneficial ownership of securities-Director Kayyem Jon Faiz
3: Initial statement of beneficial ownership of securities-10% Owner VIKING GLOBAL INVESTORS LP
SC 13G: Statement of acquisition of beneficial ownership by individuals-Viking Global Investors LP(12.3%),Viking Global Opportunities Parent GP LLC(12.3%), etc.
Inhibrx Biosciences | 4: Statement of changes in beneficial ownership of securities
Inhibrx Biosciences | SC 13D: Statement of acquisition of beneficial ownership by individuals
Inhibrx Biosciences | SC 13D: Statement of acquisition of beneficial ownership by individuals
SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Viking Global Investors LP(0.0%),Viking Global Opportunities Parent GP LLC(0.0%), etc.
4: Statement of changes in beneficial ownership of securities-10% Owner VIKING GLOBAL INVESTORS LP
Inhibrx Biosciences | SC 13G: Statement of acquisition of beneficial ownership by individuals
4: Statement of changes in beneficial ownership of securities-10% Owner Inhibrx, Inc.
No Data
No Data